Meeting Banner
Abstract #4026

MRS-based metabolomic approaches detect multiple metabolic targets for the antitumor action of metformin on U87MG glioma cells.

Marco Rinaudo1, Agnese Sacchetti1, Serena Cecchetti1, Laura Mercurio1, Maria Jose Caramujo1, Mattea Chirico1, Marika Pinazza2, Giulia Carpinelli1, Stefano Indraccolo2, Franca Podo1, and Egidio Iorio1

1Istituto Superiore di Sanità, Roma, Italy, 2IRCCS Istituto Oncologico Veneto, Padova, Italy

There is an urgent need to develop novel therapeutic strategies for malignant brain tumors. Purposes of this study were: 1) to investigate in glioma cells the alterations induced by metformin in the levels of metabolites produced by different biochemical pathways ( glycolysis and phosphatidylcholine (PC) metabolism); 2) to evaluate the possibility to enhance the antiproliferative effects of metformin by a combination of metformin with a selected inhibitor of PC metabolism. We found : a) activation of PC-plc and PCho accumulation in metformin-treated cells; b) enhanced cell death in glioma cells with a combination of metformin and the PC-plc.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords